MPWT
CSTL icon

MassMutual Private Wealth & Trust’s Castle Biosciences CSTL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-202
Closed -$4.96K – 2420
2026
Q1 		$4.96K Buy
+202
New +$6.62K ﹤0.01% 1680
2025
Q2 		– Sell
-51
Closed -$1.02K – 2382
2025
Q1 		$1.02K Sell
51
-39
-43% -$966 ﹤0.01% 2127
2024
Q4 		$2.4K Hold
90
– – ﹤0.01% 1778
2024
Q3 		$2.57K Buy
+90
New +$2.29K ﹤0.01% 1582

Other funds holding CSTL

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

MassMutual Private Wealth & Trust's CSTL Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Castle Biosciences (CSTL) in Q2 2026, closing a stake of 202 shares — an estimated $4.96K sold.

MassMutual Private Wealth & Trust first reported a position in CSTL in Q3 2024 and held it in 4 quarters. The position peaked at $4.96K in Q1 2026. 38 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining Castle Biosciences position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 202 Castle Biosciences shares in Q2 2026, an estimated $4.96K.
  • MassMutual Private Wealth & Trust first reported a position in Castle Biosciences in Q3 2024 and held it in 4 quarters.
  • MassMutual Private Wealth & Trust's Castle Biosciences position peaked at $4.96K in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.